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1. Introduction 
Post-heparin plasma contains triacylglycerol lipase 
(TGL), monoacylglycerol hydrolase (MGH) and 
phospholipase activities. On the basis of several 
criteria, these enzymes are considered to be different 
from one another [l-3] . In order to study the detailed 
properties of these enzymes, it is necessary to purify 
the enzyme from others. Nilsson-Ehle and Belfrage [4] 
reported a 7.2-fold purification of MGH in post- 
heparin plasma by removal of TGL-substrate com- 
plex, precipitation at low pH and low ionic strength, 
and molecular exclusion chromatography. In the 
present study, we have described the purification of 
MGH in human post-heparin plasma by the removal 
of TGL-substrate complex and affinity chromato- 
graphy on Sepharose 4B column containing covalently 
bound heparin. 
2. Materials and methods 
2.1. Materials 
[3H]Glyceryl monooleate was prepared from [3H]- 
glyceryl trioleate, obtained from the Radiochemical 
Centre, Amersham, by pancreatic lipase (Sigma 
Chemical Co.), purified by thin-layer chromatography, 
and was better than 98% pure. Unlabeled monoolein 
was purchased from Tokyo Kasei Kogyo Co., Ltd., 
Tokyo, purified by silicic acid column chromato- 
graphy, and was better than 95% pure. Triton X-100 
and fatty acid-poor bovine serum albumin (BSA) were 
obtained from Sigma Chemical Co., St. Louis, and 
were used without further purification. Glycerol was 
from Wako Pure Chemical Industries, Ltd., Osaka. All 
the other chemicals employed were of reagent grade. 
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2.2. Source of enzyme 
Human post-heparin plasma was obtained from 
healthy young donors who had fasted overnight. 
Blood was collected in tubes containing l/20 vol of 
0.25 M sodium citrate 10 nin after intravenous 
administration of sodium heparin of 10 units/kg of 
body weight. All samples were kept on ice and plasma 
was separated by centrifugation at 5000 g and 4°C. 
Plasma samples were then either stored at -20°C or 
used immediately. 
2.3. Enzyme assay 
Monoacylglycerol hydrolase activity assays were 
carried out by the method previously reported [S] 
using [3H]glyceryl monooleate emulsified in the 
presence of Triton X-100 as substrate. 
Triacylglycerol lipase activity was assayed with 
[3H]glyceryl trioleate substrate emulsified with 
Triton X-l 00 and fatty acid-poor BSA in the presence 
of 0.15 M NaCl and fasted plasma as previously 
described [6]. 
2.4. Enz,yme purtfication 
Post-heparin plasma was incubated with 0.1 vol 
of 20% lntralipid for 8 min at 37”C, and the resulting 
TGL-substrate complex removed by flotation in the 
ultracentrifuge at 60 000 g for 1 h at 4°C. The 
infranatant, which still contained some TGL activity, 
was transferred to new tubes and the same procedure 
repeated two more times. The final infranatant was 
diluted 10 times with 0.005 M sodium barbital buffer, 
pH 7.4, containing 0.15 M NaCl. The sample was 
applied on a Sepharose4B column (2.0 X 12.0 cm) 
containing covalently bound heparin [7]. The column 
was equilibrated with 0.15 M NaCl in 0.005 M sodium 
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barbital buffer, pH 7.4. After washing with the same 
buffer, elution was conducted with a linear NaCl 
gradient (0.5 ml per min) from 0.15 M to 2.0 M NaCl 
in 0.005 M sodium barbital buffer, pH 7.4. The total 
volume of gradient was 200 ml and fractions of 5 ml 
were collected. 
2.5. Other procedures 
Protein was determined by the method of Lowry 
et al. [8] using BSA as a standard. Chloride concentra- 
tions were determined with a Evans chloridemeter. 
3. Results and discussion 
As shown in table 1, the specific activity for MGH MGH activities in post-heparin plasma and in the 
of human post-heparin plasma is about 12 times that infranatant after treatments with Intralipid were 
of TGL. Although Nilsson-Ehle and Belfrage [4] remarkably stable and they could be stored with no 
reported no measurable TGL activity in their final loss of activity for 24 h at 4°C. Stability of the 
infranatant after five treatments with Intralipid, the purified enzyme after affinity chromatography at 
present results showed that approx. 18% of TGL 4°C was also studied. Almost 40% of the activity was 
activity remained in the final infranatant. After affinity lost during the 1st hour, after which activity was lost 
chromatography, however, almost no measurable TGL more slowly for 24 h, with a half-life of approximately 
activity was detected in the combined fraction. Recent 11 h (fig.2); This enzyme is considered more stable 
evidences from several aboratories have indicated the than the purified adipose tissue TGL, which has a 
presence of protamine- or salt-resistant lipase and half-life of only 3.5 h [ 121. The purified MGH could 
protamine- or salt-inactivated lipase in post-heparin be stabilized by the addition of either glycerol to 
plasma [9,10]. Ehnholm et al. [lo] reported that a final concentration of 20% or albumin of 1%. As 
40-45% of the salt-resistant lipase and 5- 10% of the shown in fig.2,70 and 95% of the original activity 
salt-inactivated lipase activity remained in the final were retained after 3 h in the presence of 20% 
infranatant after two treatments with Intralipid. They 
suggested that both lipases were able to bind to 
Intralipid although the affinity of the saltresistant 
lipase was lower. 
As described by Greten et al. [ 111, MGH activity 
eluted from heparin-Sepharose column with that of 
TGL (fig.1). Then, it is necessary to separate these 
two enzyme activities. Recently TGL in post-heparin 
plasma was purified by affinity chromatography on 
heparin-Sepharose. These preparations were supposed 
to contain MGH activity which was more stable than 
TGL. The present results show that the final specific 
activity of MGH is 5737 nmol glycerol liberated per 
mg protein per min, representing approx. 535-fold 
purification from post-heparin plasma. 
Table 1 




Total Specific Purifi- 
Activity Activity cation 














Peak fraction (5 ml) 
Combined fraction 
(15 ml) 
646.2 6931.8 10.7 1 100 572.4 100 12.1 
636.5 5864.3 9.2 0.9 84.6 107.0 18.7 54.8 
0.063 361.4 5736.5 535 5.2 a a 
0.225 946.8 4208.0 392 13.7 2.9 0.5 326.5 
aNot measurable. 
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Fig.1. Affinity chromatography of human post-heparin plasma MGH on heparin-Sepharose. A plasma sample (9 ml) of the final 
infranatant of Intralipid treatment, which had been diluted before, was applied on the column. 100 ml of the starting buffer were 
then applied, eluting a large protein peak not shown on the figure. A gradient between 0.15 and 2.0 M NaCl with 0.005 M sodium 
barbital buffer, pH 7.4, was then started using a total volume of 200 ml. Fractions of 5 ml were collected. (o-o) Protein 
measured by absorbance at 280 nm. (o-o) MGH activity in the assay system described under Materials and methods without 
serum. (A-A) MGH activity in the assay system with 0.08 vol of serum. (o--o) NaCl molarity. 
LL. 
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glycerol or 1% BSA, respectively. The results of 
Bensadoun et al. [12] and of the present study lead 
us to suppose that the affinity chromatography on 
heparin-Sepharose appears not only to purify the 
enzymes, but also to separate the stabilizing structure 
from the enzyme proteins. 
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Fig.2. Stability of partially purified MGH from human post- 
heparin plasma (heparin-Sepharose step) at 4°C in the absence 
and presence either of 20% glycerol or 1% bovine serum 
albumin. (o-o) No addition. (A--A) 20% glycerol. 
(O-O) 1% bovine serum albumin. 
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